In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs.
- 15 March 1994
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 91 (6), 2353-2357
- https://doi.org/10.1073/pnas.91.6.2353
Abstract
Hemophilia B is a bleeding disorder caused by mutations in the factor IX gene. The disorder is X-linked recessive with a prevalence of about 1 in 30,000 Caucasian males. Factor IX is naturally synthesized in the liver and secreted into blood. Here we report the construction of recombinant adenoviral vectors containing the canine factor IX cDNA that are capable of transducing hepatocytes in mice at high efficiencies in vivo without partial hepatectomy. The recombinant viral vector was used to treat hemophilia B dogs by direct vector infusion into the portal vasculature of deficient animals. Plasma factor IX concentrations in the treated hemophilia B dogs increased from 0 to 300% of the level present in normal dogs, resulting in complete amelioration of the disease as demonstrated by normal blood coagulation and hemostatic measurements. Although plasma factor IX concentration started to decline after a few days, therapeutic levels of factor IX persisted for 1-2 months in the treated animals. The results validate the principle of in vivo hepatic gene delivery to reconstitute the genetic deficiency in a large animal model and suggest that gene therapy is achievable when long-acting vectors are developed.Keywords
This publication has 21 references indexed in Scilit:
- Assessment of Recombinant Adenoviral Vectors for Hepatic Gene TherapyHuman Gene Therapy, 1993
- Towards gene therapy for haemophilia B using primary human keratinocytesNature Genetics, 1993
- Adenovirus–mediated in vivo gene transfer and expression in normal rat liverNature Genetics, 1992
- Gene transfer in the hemophilias: Retrospect and prospectThrombosis Research, 1992
- Widespread long-term gene transfer to mouse skeletal muscles and heart.JCI Insight, 1992
- Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes.Proceedings of the National Academy of Sciences of the United States of America, 1992
- Canine hemophilia B resulting from a point mutation with unusual consequences.Proceedings of the National Academy of Sciences, 1989
- Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand disease.Proceedings of the National Academy of Sciences, 1989
- Cloning of the herpes simplex virus ICP4 Gene in an adenovirus vector: Effects on adenovirus gene expression and replicationVirology, 1989
- A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5Virology, 1988